Imaging characteristics of metastatic chordoma.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 22592289)

Published in Jpn J Radiol on May 18, 2012

Authors

Riwa Kishimoto1, Tokuhiko Omatsu, Azusa Hasegawa, Reiko Imai, Susumu Kandatsu, Tadashi Kamada

Author Affiliations

1: Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan. riwa@nirs.go.jp

Articles by these authors

Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol (2007) 2.03

A review of update clinical results of carbon ion radiotherapy. Jpn J Clin Oncol (2012) 1.99

Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2004) 1.98

Splenic volume measurements on computed tomography utilizing automatically contouring software and its relationship with age, gender, and anthropometric parameters. Eur J Radiol (2009) 1.56

Clinical Results of Carbon Ion Radiotherapy at NIRS. J Radiat Res (2007) 1.49

Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS). J Radiat Res (2010) 1.46

Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol (2002) 1.46

Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective study. Int J Urol (2013) 1.41

Overview of clinical experiences on carbon ion radiotherapy at NIRS. Radiother Oncol (2004) 1.37

Physical performance evaluation of a 256-slice CT-scanner for four-dimensional imaging. Med Phys (2004) 1.31

Hypofractionated radiotherapy with carbon ion beams for prostate cancer. Int J Radiat Oncol Biol Phys (2005) 1.29

Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys (2007) 1.27

Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol (2003) 1.27

Results of carbon ion radiotherapy for head and neck cancer. Radiother Oncol (2012) 1.22

Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.16

Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk. Cancer (2012) 1.15

Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys (2004) 1.14

Carbon-ion radiation therapy for prostate cancer. Int J Urol (2012) 1.13

CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy. J Radiat Res (2010) 1.12

First clinical experience in carbon ion scanning beam therapy: retrospective analysis of patient positional accuracy. J Radiat Res (2012) 1.09

Four-dimensional computed tomography (4D CT)--concepts and preliminary development. Radiat Med (2003) 1.09

Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays. Cancer Res (2011) 1.09

Examination of GyE system for HIMAC carbon therapy. Int J Radiat Oncol Biol Phys (2006) 1.08

Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis. Radiother Oncol (2010) 1.08

Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.06

Four-dimensional measurement of intrafractional respiratory motion of pancreatic tumors using a 256 multi-slice CT scanner. Radiother Oncol (2009) 1.06

Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys (2003) 1.04

A combination-weighted Feldkamp-based reconstruction algorithm for cone-beam CT. Phys Med Biol (2006) 1.02

Phase 1 trial of preoperative, short-course carbon-ion radiotherapy for patients with resectable pancreatic cancer. Cancer (2012) 1.02

Three-dimensional intrafractional motion of breast during tangential breast irradiation monitored with high-sampling frequency using a real-time tumor-tracking radiotherapy system. Int J Radiat Oncol Biol Phys (2007) 1.02

Cervical spine osteosarcoma treated with carbon-ion radiotherapy. Lancet Oncol (2006) 1.01

Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials. Int J Radiat Oncol Biol Phys (2009) 1.00

Dose escalation study of carbon ion radiotherapy for locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys (2006) 0.99

Malignant mucosal melanoma treated with carbon ion radiotherapy with concurrent chemotherapy: prognostic value of pretreatment apparent diffusion coefficient (ADC). Radiother Oncol (2010) 0.98

Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography. J Neurosurg (2011) 0.98

Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience. Int J Radiat Oncol Biol Phys (2008) 0.98

A robust algorithm of intensity modulated proton therapy for critical tissue sparing and target coverage. Phys Med Biol (2011) 0.96

Carbon ion radiotherapy for unresectable sacral chordomas. Clin Cancer Res (2004) 0.96

Risk factors of late rectal bleeding after carbon ion therapy for prostate cancer. Int J Radiat Oncol Biol Phys (2006) 0.95

In vitro characterization of cells derived from chordoma cell line U-CH1 following treatment with X-rays, heavy ions and chemotherapeutic drugs. Radiat Oncol (2011) 0.95

Clinical trial of carbon ion radiotherapy for gynecological melanoma. J Radiat Res (2014) 0.95

Clinical outcomes of carbon ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix in phase 1/2 clinical trial (protocol 9704). Cancer (2014) 0.95

Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma. Ann Surg Oncol (2011) 0.94

Rapid estimation of split renal function in kidney donors using software developed for computed tomographic renal volumetry. Eur J Radiol (2009) 0.94

Clinical outcome of sacral chordoma with carbon ion radiotherapy compared with surgery. Int J Radiat Oncol Biol Phys (2010) 0.93

Impact of boost irradiation on pelvic lymph node control in patients with cervical cancer. J Radiat Res (2013) 0.93

Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: from 20 to 16 fractions. Int J Radiat Oncol Biol Phys (2012) 0.93

Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient. J Comput Assist Tomogr (2010) 0.93

Primary cardiac angiosarcoma treated with carbon-ion radiotherapy. Lancet Oncol (2004) 0.92

Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells. Radiother Oncol (2012) 0.92

Carbon-ion radiotherapy for marginal lymph node recurrences of cervical cancer after definitive radiotherapy: a case report. Radiat Oncol (2013) 0.92

Informatics in Radiology (infoRAD): mobile wireless DICOM server system and PDA with high-resolution display: feasibility of group work for radiologists. Radiographics (2005) 0.92

Impact of intrafractional bowel gas movement on carbon ion beam dose distribution in pancreatic radiotherapy. Int J Radiat Oncol Biol Phys (2009) 0.92

Impact of carbon ion radiotherapy for primary spinal sarcoma. Cancer (2013) 0.91

Specification of Carbon Ion Dose at the National Institute of Radiological Sciences (NIRS). J Radiat Res (2007) 0.91

Carbon ion radiotherapy for basal cell adenocarcinoma of the head and neck: preliminary report of six cases and review of the literature. Radiat Oncol (2010) 0.90

Carbon ion radiotherapy for skull base chordoma. Skull Base (2009) 0.90

l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy. Int J Radiat Oncol Biol Phys (2007) 0.90

Dose-volume histogram and dose-surface histogram analysis for skin reactions to carbon ion radiotherapy for bone and soft tissue sarcoma. Radiother Oncol (2009) 0.89

Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan. Phys Med Biol (2015) 0.89

Introduction of autopsy imaging redefines the concept of autopsy: 37 cases of clinical experience. Pathol Int (2003) 0.89

Combination immunotherapy with radiation and CpG-based tumor vaccination for the eradication of radio- and immuno-resistant lung carcinoma cells. Cancer Sci (2009) 0.89

Carbon ion radiotherapy for elderly patients 80 years and older with stage I non-small cell lung cancer. Lung Cancer (2008) 0.89

Carbon ion radiation therapy improves the prognosis of unresectable adult bone and soft-tissue sarcoma of the head and neck. Int J Radiat Oncol Biol Phys (2012) 0.89

[(11)C]methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy. Clin Cancer Res (2004) 0.89

A phase I/II clinical trial of preoperative short-course carbon-ion radiotherapy for patients with squamous cell carcinoma of the esophagus. J Surg Oncol (2011) 0.89

Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys (2006) 0.88

Alveolar hydatid disease of the adrenal gland: computed tomography and magnetic resonance imaging findings. Jpn J Radiol (2009) 0.88

Physiologic change in flow velocity and direction of dural venous sinuses with respiration: MR venography and flow analysis. AJNR Am J Neuroradiol (2004) 0.88

Dynamic MR findings of ductal carcinoma in situ within a fibroadenoma. Magn Reson Med Sci (2011) 0.87

ADC value and diffusion tensor imaging of prostate cancer: changes in carbon-ion radiotherapy. J Magn Reson Imaging (2008) 0.87

Effects of carbon-ion radiotherapy combined with a novel histone deacetylase inhibitor, cyclic hydroxamic-acid-containing peptide 31 in human esophageal squamous cell carcinoma. Anticancer Res (2009) 0.87